Hing Chow - SSY Group CFO and Company Secretary

CFO

Mr. Chow Hing Yeung serves as Chief Financial Officer, Company Secretary of Lijun International Pharmaceutical Co., Ltd. Mr. Chow is a member of the Hong Kong Institute of Certified Public Accountants. Mr. Chow obtained a Bachelors degree of Business Administration from the Chinese University of Hong Kong. He has more than 15 years of experience in areas of auditing, accounting and financial management. Mr. Chow was the Chief Financial Officer and Company Secretary of the Company during the period from 26 August 2011 to 10 May 2013. since 2015.
Age 44
Tenure 10 years
Phone852 2688 0869
Webhttps://www.ssygroup.com.hk
Chow obtained a Bachelor degree of Business Administration from the Chinese University of Hong Kong. He has more than 11 years of experience in areas of auditing, accounting and financial management.

SSY Group Management Efficiency

The company has return on total asset (ROA) of 0.0836 % which means that it generated a profit of $0.0836 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1775 %, meaning that it generated $0.1775 on every $100 dollars invested by stockholders. SSY Group's management efficiency ratios could be used to measure how well SSY Group manages its routine affairs as well as how well it operates its assets and liabilities.
SSY Group Limited has accumulated 1.69 B in total debt with debt to equity ratio (D/E) of 0.41, which is about average as compared to similar companies. SSY Group Limited has a current ratio of 1.97, which is within standard range for the sector. Debt can assist SSY Group until it has trouble settling it off, either with new capital or with free cash flow. So, SSY Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SSY Group Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SSY to invest in growth at high rates of return. When we think about SSY Group's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CFO Age

John CPAFranklin Street Properties
65
Matthew BattehSaia Inc
N/A
Matthew LesmeisterflyExclusive,
N/A
Michael DanielBassett Furniture Industries
63
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the Peoples Republic of China and internationally. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd. Ssy operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4684 people. SSY Group Limited [LJUIF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

SSY Group Limited Leadership Team

Elected by the shareholders, the SSY Group's board of directors comprises two types of representatives: SSY Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SSY. The board's role is to monitor SSY Group's management team and ensure that shareholders' interests are well served. SSY Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SSY Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jiguang Qu, Chairman and CEO
Hing Chow, CFO and Company Secretary
Guo Meng, Deputy Director
Xuejun Su, Executive Director

SSY Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is SSY Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in SSY Pink Sheet

If you are still planning to invest in SSY Group Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SSY Group's history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities